Refolditsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2016-09-26
Share capital
5 000,00 PLN
Activity description

Refoldit develops microfluidic technologies, nanoparticle synthesis and molecular biology methods, integrating microfluidics with machine learning. The company offers expression of toxic and membrane proteins, protein refolding protocols, microbiological and physicochemical analyses of water, food, feed, disinfectants and biocidal products, as well as a device for automating microfluidic processes.

Registered address
Frezerów 3, 20-209 Lublin, Poland
Website
refoldit.comWebsite active
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.59kMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD -236.64MedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 2.82kMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 11.78kMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2016-10-08. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $229,448.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

ProjectEU co-financing
ReFOLDIt - wysokowydajne, innowacyjne urządzenia do automatyzacji procesów tworzenia nowych leków i szczepionek, opartych na technologii mikroprzepływowej
$211.8K

Tenders

No recorded participation in tenders.

Authorized Representatives

Monika Dźwierzyńska – Management Board Member
Karol Sowiński – President of the Management Board
Radosław Szlązak – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Monika Dźwierzyńska (40)
13$175.5813%
Karol Sowiński (37)
72$972.4572%
Radosław Szlązak (39)
10$135.0610%
Others
5$67.535%

Beneficial owners

Person

Competitors

Name
Micropurasp. z o.o.
InventroS.A.
Detoxedsp. z o.o.
Microbiota Medsp. z o.o.
Fusiomicasp. z o.o.
2loop Techsp. z o.o.
Omnisepticasp. z o.o.
Microanalysissp. z o.o.
Möbius Labsp. z o.o.
Resolvisp. z o.o.

Change history

DateEvent
2026-10-12Address change
2026-09-01Business suspended
2017-06-07Address change
2016-09-26Entered in the register

FAQ

Last updated: 2026-10-12